Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor

被引:43
作者
Mazurkiewicz-Munoz, Anna M.
Argetsinger, Lawrence S.
Kouadio, Jean-Louis K.
Stensballe, Allan
Jensen, Ole N.
Cline, Joel M.
Carter-Su, Christin [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA
[3] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark
关键词
D O I
10.1128/MCB.01591-05
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tyrosine kinase JAK2 is a key signaling. protein for at least 20 receptors in the cytokine/hematopoietin receptor superfamilly and is a component of signaling for multiple receptor tyrosine kinases and several G-protein-coupled receptors. In this study, phosphopeptide affinity enrichment and mass spectrometry identified serine 523 (Ser523) in JAK2 as a site of phosphorylation. A phosphoserine 523 antibody revealed that Ser523 is rapidly but transiently phosphorylated in response to growth hormone (GH). MEK1 inhibitor UO126 suppresses GH-dependent phosphorylation of Ser523, suggesting that extracellular signal-regulated kinases (ERKs) 1 and/or 2 or another kinase downstream of MEK1 phosphorylate Ser523 in response to GH. Other ERK activators, phorbol 12-myristate 13-acetate and epidermal growth factor, also stimulate phosphorylation of Ser523. When Ser523 in JAK2 was mutated, JAK2 kinase activity as well as GH-dependent tyrosyl phosphorylation of JAK2 and Stat5 was enhanced, suggesting that phosphorylation of Ser523 inhibits JAK2 kinase activity. We hypothesize that phosphorylation of Ser523 in JAK2 by ERKs 1 and/or 2 or other as-yet-unidentified kinases acts in a negative feedback manner to dampen activation of JAK2 in response to GH and provides a mechanism by which prior exposure to environmental factors that regulate Ser523 phosphorylation might modulate the cell's response to GH.
引用
收藏
页码:4052 / 4062
页数:11
相关论文
共 80 条
[2]   Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity [J].
Argetsinger, LS ;
Kouadio, JLK ;
Steen, H ;
Stensballe, A ;
Jensen, ON ;
Carter-Su, C .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (11) :4955-4967
[3]   IDENTIFICATION OF JAK2 AS A GROWTH-HORMONE RECEPTOR-ASSOCIATED TYROSINE KINASE [J].
ARGETSINGER, LS ;
CAMPBELL, GS ;
YANG, XN ;
WITTHUHN, BA ;
SILVENNOINEN, O ;
IHLE, JN ;
CARTERSU, C .
CELL, 1993, 74 (02) :237-244
[4]   Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling [J].
Argetsinger, LS ;
Norstedt, G ;
Billestrup, N ;
White, MF ;
CarterSu, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29415-29421
[5]   Mechanism of signaling by growth hormone receptor [J].
Argetsinger, LS ;
CarterSu, C .
PHYSIOLOGICAL REVIEWS, 1996, 76 (04) :1089-1107
[6]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[7]  
BLUMBERG PM, 1985, CIBA F SYMP, V116, P205
[8]   Move over protein kinase C, you've got company: Alternative cellular effectors of diacylglycerol and phorbol esters [J].
Brose, N ;
Rosenmund, C .
JOURNAL OF CELL SCIENCE, 2002, 115 (23) :4399-4411
[9]  
CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074
[10]   Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways [J].
Candotti, F ;
Notarangelo, L ;
Visconti, R ;
O'Shea, J .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (10) :1261-1269